The Trump administration is touting leucovorin—a little-known medication—as a potential therapy for autism. Doctors and scientists warn its benefits might be overstated and more research is needed.

Medical groups are pushing back against President Trump's claims that acetaminophen use during pregnancy is linked to rising autism rates. This controversy has sparked significant discussion on social media about the safety of medications during pregnancy, highlighting the importance of relying on scientific evidence rather than unverified assertions. The backlash from medical professionals underscores the need for accurate information in public health discussions.

In a groundbreaking development, doctors have announced the first successful treatment for Huntington's disease, a condition that has long been considered devastating. This new treatment not only slows the progression of the disease but also has the potential to transform the lives of those affected. The news has brought tears of joy to medical professionals, highlighting the significance of this breakthrough in providing hope to patients and their families.

RFK Jr. is raising concerns about the increasing rates of autism and is calling for a deeper investigation into its causes. However, scientists argue that he is overlooking established scientific evidence that already explains many factors contributing to this rise. This debate is significant as it highlights the importance of relying on scientific consensus when discussing public health issues.

A notable number of doctors and policymakers are expressing concerns about the federal health guidance led by Robert F. Kennedy Jr., prompting them to establish an alternative public-health framework. This shift is significant as it reflects a growing distrust in established health protocols, which could lead to fragmented healthcare practices and varying standards of care across the country.

Following President Donald Trump's assertion that acetaminophen use during pregnancy may increase autism risk, medical professionals are reassuring expectant mothers that their recommendations remain unchanged. This is significant as it highlights the importance of clear communication in healthcare, especially regarding medications during pregnancy, ensuring that patients receive consistent and evidence-based guidance.

Recent discussions have emerged around leucovorin, a medication praised by the Trump administration for its potential to alleviate certain autism symptoms. However, experts in the field are urging caution, emphasizing the need for more comprehensive studies before considering its widespread use in children and adults. This highlights the ongoing debate about treatment options for autism and the importance of thorough research in ensuring safety and efficacy.

President Trump has once again strayed from scientific consensus, this time warning pregnant women about an unproven link between acetaminophen and autism. This kind of misinformation can have serious implications for public health, especially during a pandemic when accurate information is crucial. His previous controversial statements, like suggesting bleach as a treatment for COVID-19, raise concerns about the impact of his words on vulnerable populations.

Dr. Andrea Baccarelli, a Harvard dean, received $150,000 for his role as an expert witness in lawsuits concerning Tylenol. The Trump administration has referenced his expertise to caution against the use of acetaminophen during pregnancy, citing an unproven connection to autism. This news is significant as it highlights ongoing debates about medication safety during pregnancy and the implications of expert testimony in legal cases.

A judge has ordered the National Institutes of Health to restore suspended research grants at UCLA, marking a significant victory for the university in its ongoing lawsuit against the Trump administration. This ruling is crucial as it not only allows UCLA to access vital funding for research but also sets a precedent for other institutions facing similar challenges. The reinstatement of these grants could lead to advancements in various fields, benefiting both the academic community and the public.

The debate surrounding Tylenol and its potential link to autism continues, with President Trump's assertions adding to the confusion. Parents are left navigating this complex issue, as the scientific evidence remains inconclusive. It's crucial for families to stay informed and make decisions based on the best available information regarding acetaminophen use.

World health officials have firmly rejected President Trump's claims that Tylenol could be linked to autism, particularly for pregnant women. This is significant because it highlights the importance of relying on scientific evidence over unverified assertions, especially when it comes to the health of expectant mothers and their babies. The World Health Organization reassures that Tylenol is safe to use during pregnancy, emphasizing the need for accurate information in public health discussions.

President Trump recently shared his strong feelings about autism, calling it one of the most alarming public health developments. While his remarks were passionate, they raised eyebrows due to their scientific accuracy. He acknowledged that his views diverged from those of health officials like Robert F. Kennedy Jr. and the F.D.A. commissioner, who offered more measured statements. This discussion is significant as it highlights the ongoing debate around autism and public health policies, reflecting the complexities of addressing such a sensitive issue.

Louise Vincent, a pivotal figure in the harm reduction movement, has passed away at the age of 49. She played a crucial role in advocating for needle exchanges and the use of naloxone, which helps prevent overdose deaths. Her efforts not only provided essential resources for drug users but also aimed to reduce the stigma surrounding addiction. Vincent's legacy will continue to influence public health policies and support systems for those affected by substance use.

Maria Branyas Morera, recognized as the world's oldest person, has sparked interest among researchers in Spain who attribute her remarkable longevity to a combination of genetic factors. While they suggest she won a 'genetic lottery,' experts emphasize that genetics and microbiomes alone cannot fully explain why some people live exceptionally long lives. This discussion is important as it sheds light on the complex interplay of genetics, lifestyle, and environmental factors in aging, encouraging further research into how we can promote healthier, longer lives.

Dr. Deirdre Tobias, an obesity and nutritional epidemiologist, highlights the benefits of chia seeds as a great source of fiber. While they can enhance your diet, she emphasizes the importance of maintaining a balanced nutritional intake. This insight is crucial as many people look for simple ways to improve their health, and understanding the role of fiber can lead to better dietary choices.

Selma Blair, the talented actor and advocate, is embracing new adventures as she celebrates being 'relapse-free' from multiple sclerosis for a couple of years. In a recent appearance on TODAY, she shared her excitement about leading a TEDX talk focused on learning from failures and setting personal goals. Blair also highlighted her pride in receiving the key to her hometown and her journey as a mother to a teenager, all while serving as a paid spokesperson for the skincare brand ESK. Her story is a powerful reminder of resilience and the importance of pursuing one's passions.

In a recent segment on TODAY, Dr. Natalie Azar and nutrition expert Joy Bauer discussed the importance of gut health and how it affects overall well-being. They explained what the gut microbiome is, how to recognize signs of imbalance, and shared practical lifestyle changes to enhance gut health. This information is crucial as it empowers viewers to take charge of their health through informed dietary choices and habits.

The impending expiration of extensive subsidies under the Affordable Care Act, commonly known as Obamacare, could lead to a significant increase in premium costs for millions of Americans next year. This situation is critical as it highlights the ongoing debate in Congress about healthcare affordability and access, which affects many families and individuals relying on these subsidies for their health insurance.